Key result
The NCX inhibitor SEA0400 reduced proarrhythmic spontaneous Ca2+ transients in NCX overexpressing mice but increased them and induced Ca2+ overload in wild-type and NCX knockout mice.
Why the study?
Does SEA0400 affect Ca2+ transient amplitude and proarrhythmia in murine models with altered NCX expression?
Does SEA0400 affect Ca2+ transient amplitude and proarrhythmia in murine models with altered NCX expression?
p-value: p=<0.05
The antiarrhythmic and inotropic effects of the NCX inhibitor SEA0400 are critically dependent on the baseline NCX expression level, supporting its potential therapeutic use in conditions with NCX upregulation such as heart failure and atrial fibrillation.
May have context-dependent effects on Ca2+ transients; leaves open therapeutic window for NCX inhibition in arrhythmia.
Background/Objective: The cardiac Na+/Ca2+-exchanger (NCX) has been identified as a promising target to counter arrhythmia in previous studies investigating the benefit of NCX-inhibition. However, the consequences of NCX-inhibition have not been investigated in the setting of altered NCX-expression and -function, which is essential, since major cardiac diseases (heart failure/atrial fibrillation) exhibit NCX-upregulation. Thus, we here investigated the effects of the NCX-inhibitor SEA0400 on the Ca2+ transient amplitude and on proarrhythmia in homozygous-NCX-overexpressor (OE) and heterozygous-NCX-knockout (hetKO) mice compared to corresponding wild-types (WTOE/WhetKO). Methods/Results: Ca2+-transients of field-stimulated isolated ventricular cardiomyocytes were recorded with fluo-4-AM or indo-1-AM. SEA0400 (1µM) significantly reduced NCX-forward-mode function in all mouse lines. SEA0400 (1µM) significantly increased the amplitude of field-stimulated Ca2+-transients in WTOE, WThetKO and hetKO, but not in OE (% of basal; OE=98.7±5.0; WTOE=137.8±5.2*; WThetKO=126.3±6.0*; hetKO=140.6±12.8*; *p<0.05 vs basal). SEA0400 (1µM) significantly reduced the number of proarrhythmic spontaneous-Ca2+-transients (sCR) in OE, but increased it in WTOE, WThetKO and hetKO (sCR per cell; basal/+SEA0400; OE=12.5/3.7; WTOE=0.2/2.4; WThetKO=1.3/8.8; hetKO=0.2/5.5) and induced Ca2+-overload with subsequent cell death in hetKO. Conclusion: The effects of SEA0400 on Ca2+ transient amplitude and the occurrence of spontaneous Ca2+-transients as a proxy measure for inotropy and cellular proarrhythmia depend on the NCX-expression level. The antiarrhythmic effect of SEA0400 in conditions of increased NCX-expression promotes the therapeutic concept of NCX-inhibition in heart failure/atrial fibrillation. Conversely, in conditions of reduced NCX-expression, SEA0400 suppressed the NCX-function below a critical level leading to adverse Ca2+-accumulation as reflected by an increase in Ca2+ transient amplitude, proarrhythmia and cell death. Thus, the remaining NCX-function under inhibition may be a critical factor determining the inotropic and antiarrhythmic efficacy of SEA0400.
No takes yet. Share an insight, caveat, or question.
Bögeholz et al. (2017) studied Arrhythmia and Heart Failure (Altered NCX Expression). SEA0400 vs. Basal conditions (absence of SEA0400) was evaluated on Ca2+ transient amplitude and number of proarrhythmic spontaneous Ca2+ transients (sCR) (p=<0.05). The NCX inhibitor SEA0400 reduced proarrhythmic spontaneous Ca2+ transients in NCX overexpressing mice but increased them and induced Ca2+ overload in wild-type and NCX knockout mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: